Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy

Alexander Neumeister, Erick Turner, Jefferey R. Matthews, Teodor T. Postolache, Ronald L. Barnett, Manfred Rauh, Rina G. Vetticad, Siegfried Kasper, Norman E. Rosenthal

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Background: Although hypotheses about the therapeutic mechanism of action of light therapy have focused on serotonergic mechanisms, the potential role, if any, of catecholaminergic pathways has not been fully explored. Methods: Sixteen patients with seasonal affective disorder who had responded to a standard regimen of daily 10000-lux light therapy were enrolled in a doubleblind, placebo-controlled, randomized crossover study. We compared the effects of tryptophan depletion with catecholamine depletion and sham depletion. Ingestion of a tryptophan-free amino acid beverage plus amino acid capsules was used to deplete tryptophan. Administration of the tyrosine hydroxylase inhibitor α-methyl-paratyrosine was used to deplete catecholamines. Diphenhydramine hydrochloride was used as an active placebo during sham depletion. The effects of these interventions were evaluated with measures of depression, plasma tryptophan levels, and plasma catecholamine metabolites. Results: Tryptophan depletion significantly decreased plasma total and free tryptophan levels. Catecholamine depletion significantly decreased plasma 3-methoxy-4- hydroxyphenylethyleneglycol and homovanillic acid levels. Both tryptophan depletion and catecholamine depletion, compared with sham depletion, induced a robust increase (P<.001, repeated-measures analysis of variance) in depressive symptoms as measured with the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version. Conclusions: The beneficial effects of light therapy in the treatment of seasonal affective disorder are reversed by both tryptophan depletion and catecholamine depletion. These findings confirm previous work showing that serotonin plays an important role in the mechanism of action of light therapy and provide new evidence that brain catecholaminergic systems may also be involved.

Original languageEnglish (US)
Pages (from-to)524-530
Number of pages7
JournalArchives of General Psychiatry
Volume55
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Seasonal Affective Disorder
Phototherapy
Tryptophan
Catecholamines
Depression
Placebos
Amino Acids
Diphenhydramine
Homovanillic Acid
Beverages
Tyrosine 3-Monooxygenase
Cross-Over Studies
Capsules
Serotonin
Analysis of Variance
Eating

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. / Neumeister, Alexander; Turner, Erick; Matthews, Jefferey R.; Postolache, Teodor T.; Barnett, Ronald L.; Rauh, Manfred; Vetticad, Rina G.; Kasper, Siegfried; Rosenthal, Norman E.

In: Archives of General Psychiatry, Vol. 55, No. 6, 1998, p. 524-530.

Research output: Contribution to journalArticle

Neumeister, A, Turner, E, Matthews, JR, Postolache, TT, Barnett, RL, Rauh, M, Vetticad, RG, Kasper, S & Rosenthal, NE 1998, 'Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy', Archives of General Psychiatry, vol. 55, no. 6, pp. 524-530. https://doi.org/10.1001/archpsyc.55.6.524
Neumeister, Alexander ; Turner, Erick ; Matthews, Jefferey R. ; Postolache, Teodor T. ; Barnett, Ronald L. ; Rauh, Manfred ; Vetticad, Rina G. ; Kasper, Siegfried ; Rosenthal, Norman E. / Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. In: Archives of General Psychiatry. 1998 ; Vol. 55, No. 6. pp. 524-530.
@article{e486e95263d64ac2943f71233dbe391e,
title = "Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy",
abstract = "Background: Although hypotheses about the therapeutic mechanism of action of light therapy have focused on serotonergic mechanisms, the potential role, if any, of catecholaminergic pathways has not been fully explored. Methods: Sixteen patients with seasonal affective disorder who had responded to a standard regimen of daily 10000-lux light therapy were enrolled in a doubleblind, placebo-controlled, randomized crossover study. We compared the effects of tryptophan depletion with catecholamine depletion and sham depletion. Ingestion of a tryptophan-free amino acid beverage plus amino acid capsules was used to deplete tryptophan. Administration of the tyrosine hydroxylase inhibitor α-methyl-paratyrosine was used to deplete catecholamines. Diphenhydramine hydrochloride was used as an active placebo during sham depletion. The effects of these interventions were evaluated with measures of depression, plasma tryptophan levels, and plasma catecholamine metabolites. Results: Tryptophan depletion significantly decreased plasma total and free tryptophan levels. Catecholamine depletion significantly decreased plasma 3-methoxy-4- hydroxyphenylethyleneglycol and homovanillic acid levels. Both tryptophan depletion and catecholamine depletion, compared with sham depletion, induced a robust increase (P<.001, repeated-measures analysis of variance) in depressive symptoms as measured with the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version. Conclusions: The beneficial effects of light therapy in the treatment of seasonal affective disorder are reversed by both tryptophan depletion and catecholamine depletion. These findings confirm previous work showing that serotonin plays an important role in the mechanism of action of light therapy and provide new evidence that brain catecholaminergic systems may also be involved.",
author = "Alexander Neumeister and Erick Turner and Matthews, {Jefferey R.} and Postolache, {Teodor T.} and Barnett, {Ronald L.} and Manfred Rauh and Vetticad, {Rina G.} and Siegfried Kasper and Rosenthal, {Norman E.}",
year = "1998",
doi = "10.1001/archpsyc.55.6.524",
language = "English (US)",
volume = "55",
pages = "524--530",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy

AU - Neumeister, Alexander

AU - Turner, Erick

AU - Matthews, Jefferey R.

AU - Postolache, Teodor T.

AU - Barnett, Ronald L.

AU - Rauh, Manfred

AU - Vetticad, Rina G.

AU - Kasper, Siegfried

AU - Rosenthal, Norman E.

PY - 1998

Y1 - 1998

N2 - Background: Although hypotheses about the therapeutic mechanism of action of light therapy have focused on serotonergic mechanisms, the potential role, if any, of catecholaminergic pathways has not been fully explored. Methods: Sixteen patients with seasonal affective disorder who had responded to a standard regimen of daily 10000-lux light therapy were enrolled in a doubleblind, placebo-controlled, randomized crossover study. We compared the effects of tryptophan depletion with catecholamine depletion and sham depletion. Ingestion of a tryptophan-free amino acid beverage plus amino acid capsules was used to deplete tryptophan. Administration of the tyrosine hydroxylase inhibitor α-methyl-paratyrosine was used to deplete catecholamines. Diphenhydramine hydrochloride was used as an active placebo during sham depletion. The effects of these interventions were evaluated with measures of depression, plasma tryptophan levels, and plasma catecholamine metabolites. Results: Tryptophan depletion significantly decreased plasma total and free tryptophan levels. Catecholamine depletion significantly decreased plasma 3-methoxy-4- hydroxyphenylethyleneglycol and homovanillic acid levels. Both tryptophan depletion and catecholamine depletion, compared with sham depletion, induced a robust increase (P<.001, repeated-measures analysis of variance) in depressive symptoms as measured with the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version. Conclusions: The beneficial effects of light therapy in the treatment of seasonal affective disorder are reversed by both tryptophan depletion and catecholamine depletion. These findings confirm previous work showing that serotonin plays an important role in the mechanism of action of light therapy and provide new evidence that brain catecholaminergic systems may also be involved.

AB - Background: Although hypotheses about the therapeutic mechanism of action of light therapy have focused on serotonergic mechanisms, the potential role, if any, of catecholaminergic pathways has not been fully explored. Methods: Sixteen patients with seasonal affective disorder who had responded to a standard regimen of daily 10000-lux light therapy were enrolled in a doubleblind, placebo-controlled, randomized crossover study. We compared the effects of tryptophan depletion with catecholamine depletion and sham depletion. Ingestion of a tryptophan-free amino acid beverage plus amino acid capsules was used to deplete tryptophan. Administration of the tyrosine hydroxylase inhibitor α-methyl-paratyrosine was used to deplete catecholamines. Diphenhydramine hydrochloride was used as an active placebo during sham depletion. The effects of these interventions were evaluated with measures of depression, plasma tryptophan levels, and plasma catecholamine metabolites. Results: Tryptophan depletion significantly decreased plasma total and free tryptophan levels. Catecholamine depletion significantly decreased plasma 3-methoxy-4- hydroxyphenylethyleneglycol and homovanillic acid levels. Both tryptophan depletion and catecholamine depletion, compared with sham depletion, induced a robust increase (P<.001, repeated-measures analysis of variance) in depressive symptoms as measured with the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version. Conclusions: The beneficial effects of light therapy in the treatment of seasonal affective disorder are reversed by both tryptophan depletion and catecholamine depletion. These findings confirm previous work showing that serotonin plays an important role in the mechanism of action of light therapy and provide new evidence that brain catecholaminergic systems may also be involved.

UR - http://www.scopus.com/inward/record.url?scp=0031776485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031776485&partnerID=8YFLogxK

U2 - 10.1001/archpsyc.55.6.524

DO - 10.1001/archpsyc.55.6.524

M3 - Article

C2 - 9633671

AN - SCOPUS:0031776485

VL - 55

SP - 524

EP - 530

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 6

ER -